Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Chronic kidney disease (CKD) is a progressive loss of kidney
function over months or years. The majority of CKD patients ultimately
reach ESRD and need RRT. Hemodialysis is one of the treatment options for
end-stage renal disease (ESRD). Excessive fluid gain between hemodialysis
sessions is one crucial factor associated with hypertension and shortened
survival for patients. In addition, excessive weight gain between hemodialysis
predisposes to an increase in the risk of intradialytic hypotension or morbidity
due to corresponding increased ultrafiltration rates when the duration
of dialysis sessions cannot be extended. Many studies have shown that
increased IDWG is associated with increased glycosylated hemoglobin. The
glycosylated hemoglobin (HbA1c) test has been the most widely accepted,
reliable biomarker for evaluating long-term glycemic control in patients with
diabetes mellitus. Diabetic patients on MHD have increased thirst, and a
recent multi-center study showed that they were more likely to have more
significant interdialytic weight gain than nondiabetic patients. Aim of the
study: To determine the association between interdialytic weight gain and
glycosylated hemoglobin in diabetic patients on maintenance hemodialysis.
This hospital-based prospective analytical study was conducted
at the Department of Nephrology, Dhaka Medical College. A total of
109 diabetic patients with MHD were included in this study according
to selection criteria. HbA1c was determined for each patient. IDWG was
calculated from two weights measured between two dialysis sessions. A
pretested questionnaire was used for the interview. Informed written consent
was obtained. Seventeen patients were dropped out, so, finally, data were
analyzed for 92 patients. ANOVA, Student's t-test, and Chi-squared test were
carried out. Following the completion of data collection, data were analyzed
using SPSS version 26.
The mean age of the patients was 45.86±14.10 years, ranging from
23-78 years. Males (65.2%) were predominant than females (34.8%). Male
to female ratio was 1.88:1. HbA1c level was significantly elevated as age
increased (p=0.037). Sixty-one (66.3%) patients had interdialytic weight gain.
Mean weight gain was 2.88±1.04 kg, ranging from 0.6 kg to 4.67 kg. Among
the study subjects, 15.2%, 30.4%, and 54.3% had HbA1c ≤6%, 6.1-7.9%, and
≥8%, respectively. A significant (p=0.023) association was observed. HbA1c
was elevated as the increment of IDWG. There was a significant positive
correlation between HbA1c and IDWG (r=0.365; p<0.001). Interdialytic
weight gain decreased as per increment of the duration of dialysis. There was
a significant negative correlation between interdialytic weight gain and the
duration of dialysis (r= -0.382; p<0.001).
The results of this study demonstrated that interdialytic weight
gain (IDWG) is positively correlated with high HbA1c and inversely related
to the duration of dialysis.
